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Alzheimerdisease(AD)andcerebrovascularaccidents
(CVA) are the two leading causes of age-related demen-
tia. The risk of AD, stroke, and CVA are known to in-
crease at comparable rates with age. Recent advances on
several fronts suggest that the vascular risk factors, which
are linked to cerebrovascular disease and stroke in the
elderly, signiﬁcantly increase the risk of AD. Although
some vascular lesions (eg, cerebral amyloid angiopathy,
endothelial degeneration, and periventricular white mat-
ter lesions) are evident in most AD cases, fully one third
of these cases will exhibit cerebral infarcts. Despite the in-
terpretation of pathological evidence, longitudinal clini-
cal studies suggest that stroke and AD occur in tandem
more often than by chance alone. Strokes often occur in
patients with AD and have been linked to the pathogene-
sis of dementia. Nevertheless, the nature of this relation-
ship remains largely unexplored. Irrespective of the ulti-
mate pathogenic mechanism, these ﬁndings suggest that
managing vascular disease is important in the treatment
and prevention of AD or mixed dementia.
Increasing evidence supports the notion that the un-
derlying mechanism responsible for CVA is also respon-
sible for AD-related dementia. The implicated pathogen-
esis, which is primarily responsible for both disease pro-
cesses, seems to involve chronic hypoperfusion. Hypop-
erfusion appears to induce chronic oxidative damage in
tissues and cells, largely due to the generation of reactive
oxygen and reactive nitrogen species (ROS and RNS, re-
spectively). Any condition, which outpaces the capacity of
endogenous redox systems to neutralize such toxic inter-
mediates, leads to a system imbalance or to major com-
pensatory adjustments that rebalance the system. This
new redox stateis generallyreferredto as“oxidative stress”
and is associated with other age-related degenerative dis-
orders, such as atherosclerosis, ischemia/reperfusion, and
rheumatic disorders. Chronic injury stimuli can also in-
duce hypoperfusion in the microcirculation of vulnerable
brain regions.
Many common disease risk factors may underlie and
play key roles in the development of cardiovascular, cere-
brovascular, and neurodegenerative diseases. For exam-
ple, it has been widely accepted that hypercholesterolemia
is a risk factor for the development of cardiovascu-
lar and cerebrovascular disease as well as AD. Vascu-
lar insuﬃciency/hypoperfusion also is considered to be a
pathogenic factor in the development of AD. Further, the
positive relationship between cerebrovascular diseases,
such as stroke and especially cerebrovascular atheroscle-
rosis, indicates that the latter may also be linked to the
pathogenesis of AD. In addition, ischemia/reperfusion in-
duce chronic hypoxic conditions, which cause the for-
mation of a large amount of oxygen free radicals, which
also appear to be a key factor in the development of
these diseases. In support of this notion, new evidence
hasimmerged,whichindicatesthatcontinuousformation
of oxygen free radicals induces cellular damage and de-
creases antioxidant defenses. The vascular endothelium,
neurons,andgliaareallabletosynthesizeandreleaseROS
and vasoactive substances in response to certain stim-
uli, especially that of chronic hypoxia/hypoperfusion. The
contribution of these substances to the pathogenesis of
CVA and AD is extremely important. The role of hypop-
erfusion, as a key factor for vascular lesion formation and
which causes oxidative stress, appears to be widely ac-
cepted as an initiator of AD. This idea is based on a pos-
itive correlation between AD and cardiovascular diseases.
ROS are generated at sites of injury and/or inﬂammation.
The vascular endothelium, which regulates the pas-
sage of macromolecules and circulating cells from the
blood to tissues, is a major target of oxidant stress and
plays a critical role in the pathogenesis of several vascu-
lar diseases. Speciﬁcally, accumulated oxidative stress in-
creases vascular endothelial permeability and promotes
leukocyte adhesion, followed by alterations in endothe-
lial signal transduction and redox-regulated transcription
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mechanisms, by which hypoperfusion-induced ROS ac-
cumulation impairs endothelial barrier function and pro-
motes leukocyte adhesion, induce alterations in nor-
mal vascular function and result in the development of
AD. Sustained hypoperfusion with concomitant oxidative
stresstobraintissuescouldalsostimulatesecondarydam-
age via the overexpression of inducible and neuronal spe-
ciﬁcnitricoxidesynthase(NOS:iNOSandnNOS,respec-
tively) and endothelin-1 (ET-1) in brain cells. It is possi-
ble that continuous production of oxidative stress prod-
ucts, such as peroxynitrite accumulation (via the over-
expression of the iNOS and/or nNOS), may appear to
be secondary and accelerating factors for damage and
for compromising the blood-brain barrier (BBB) in hy-
poxia/hypoperfusion or AD.
One of the main eﬀects of chronic hypoperfusion-
induced vascular abnormalities in AD appears to be tissue
oxygen deﬁciency. Recent evidence supports a critical role
for chronic cerebral hypoperfusion in the development of
cognitive impairments such as AD. When seen together
with AD, accumulating evidence reveals that a greater
fraction of oxygen is removed from the vasculature in AD
patients as compared to non-AD controls. Therefore, low
vascular blood ﬂow, a prominent feature of the brain dur-
ing chronic hypoxia/hypoperfusion, may be a priming (or
initiating) factor in the development and maturation of
AD. These metabolic defects are present before the devel-
opment of AD symptoms in apolipoprotein E (ApoE) ε4
homozygote patients. De la Torre proposes that advanc-
ing age with a comorbid condition, such as a vascular
risk factor that further decreases cerebral perfusion, pro-
motes a critically attained threshold of cerebral hypoper-
fusion (CATCH). With time, CATCH induces brain capil-
lary degeneration and suboptimal delivery of energy sub-
strates to neuronal tissue. Because glucose is the main fuel
of brain cells, its impaired delivery, together with a de-
ﬁcient delivery of oxygen, compromises neuronal stabil-
ity because the supply for aerobic glycolysis fails to meet
the brain tissue demand. The outcome of CATCH is a
metabolic cascade that involves, among other things, mi-
tochondrial dysfunction, oxidative stress, decreased pro-
duction of adenosine triphosphate (ATP) and other re-
ducing equivalents of (NADH/NADPH), increased cal-
cium entry, abnormal protein synthesis, cell ionic pump
deﬁciency, signal transduction defects, and neurotrans-
mission failure. These events contribute to the progres-
sivecognitivedeclinecharacteristicofpatientswithAD,as
well as regional anatomic pathology, consisting of synap-
tic loss, senile plaque formation (SP), neuroﬁbrillary tan-
gles (NFT), tissue atrophy, vasculopathy, and neurode-
generation.CATCHidentiﬁestheclinicalheterogenicpat-
tern, which characterizes AD because it provides com-
pelling evidence that any of a multitude of diﬀerent
etiopathophysiologic vascular risk factors, in the pres-
ence of advancing age, may lead to AD. We hypothesize
that, taken together with vascular endothelial cells (EC)
and smooth muscle cell (SMC) abnormalities induced by
hypoperfusion, these are key factors in impaired tissue
oxygen delivery and therefore appear to be main reason
for the development of AD.
Importantly, the reduced energy production found in
hypoperfusion may lead to energy failure. This failure ul-
timately manifests itself as damage to mitochondrial ul-
trastructure in the diﬀerent brain cellular compartments.
Ultrastructural impairments include the formation of a
large number of nonmature or the so-called “young,”
electron-dense “hypoxic” mitochondria and overprolifer-
ation of abnormal mitochondrial DNA (mtDNA). Addi-
tionally, these mitochondrial abnormalities are found to
coexist with increased redox metal activity, overexpres-
sion of lipid peroxidation markers, and with RNA ox-
idation. This oxidative stress occurs within various cel-
lular compartments, most notably in neurons and vas-
cular EC, and is responsible for atherosclerotic damage.
Nevertheless, vulnerable neurons and associated glial cells
show mtDNA deletions and overexpression of oxidative
stress markers only in regions proximal to the damaged
vessels which also show the same pattern of mitochon-
drial abnormality and oxidative stress marker overexpres-
sion. This evidence strongly indicates that it is chronic
hypoperfusion that induces lesions and causes the accu-
mulation of the oxidative stress products seen in AD. De-
termining the mechanisms, which underlie these imbal-
ances, may provide crucial information in the develop-
ment of new, more eﬀective therapies for the treatment
of cerebrovascular diseases, including AD. Therefore, any
pharmacological intervention, directed at correcting the
chronic hypoperfusion state, would possibly change the
naturalcourseofdevelopmentofdementingneurodegen-
eration.
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